isotretinoin and Skin-Diseases--Bacterial

isotretinoin has been researched along with Skin-Diseases--Bacterial* in 2 studies

Reviews

1 review(s) available for isotretinoin and Skin-Diseases--Bacterial

ArticleYear
Acne pathogenesis: history of concepts.
    Dermatology (Basel, Switzerland), 2014, Volume: 229, Issue:1

    From the first reliable descriptions of acne in the early 19th century, dermatologists recognized it as a disease of the pilosebaceous follicle. Until the middle of the 20th century, they hypothesized that seborrhoea, follicular keratosis and microorganisms could be individually responsible for the acne lesions. Inflammation was only regarded as the final and inescapable step of the acne process. Although the importance of these factors has been reevaluated, recent works still regarded them as mandatory. In the 1970s, the onset of isotretinoin dramatically improved acne management. It also provided great opportunities for a better understanding of the pathogenic factors of acne. This study analyzes their genesis and development from the seminal contributions until recent advances.

    Topics: Acne Vulgaris; Animals; Anti-Bacterial Agents; Dermatitis, Seborrheic; Dermatologic Agents; Diet; Gram-Positive Bacterial Infections; History, 16th Century; History, 17th Century; History, 18th Century; History, 19th Century; History, 20th Century; History, 21st Century; Hormones; Humans; Inflammation; Isotretinoin; Propionibacterium acnes; Sebum; Skin Diseases, Bacterial; Vitamin A

2014

Trials

1 trial(s) available for isotretinoin and Skin-Diseases--Bacterial

ArticleYear
Efficacy of oral isotretinoin in the control of skin and nasal colonization by antibiotic-resistant propionibacteria in patients with acne.
    The British journal of dermatology, 2005, Volume: 153, Issue:6

    Skin colonization by antibiotic-resistant propionibacteria is commonplace among acne patients globally. Increasing attention is now being paid to how resistance rates might be reduced to preserve the future efficacy of antibiotics, especially erythromycin and clindamycin in acne therapy.. To assess the efficacy of oral isotretinoin in the control of antibiotic-resistant propionibacteria.. Acne patients (72 in the U.K., 62 in the U.S.A.) colonized with high numbers of antibiotic-resistant propionibacteria were sampled before, during and 12 weeks after oral isotretinoin therapy. Propionibacterial samples were collected from five acne-prone skin surface sites using a detergent scrub method and from the anterior nares using moistened swabs. Total and antibiotic-resistant propionibacteria were enumerated by viable counting on media with and without selective antibiotics.. After 16 weeks of oral isotretinoin therapy, mean population densities of viable propionibacteria and variants resistant to erythromycin, clindamycin or tetracycline had fallen by more than 90% at all skin sites and in the nares. The sole exception was a smaller reduction in tetracycline-resistant strains on the lower back. In general, greater reductions were observed on skin than in the nares. By the end of the treatment period only three patients (all in Philadelphia) yielded no antibiotic-resistant strains from any site. Post-treatment, propionibacterial counts remained well below pretreatment levels but had begun to recover on the face and in the nares. The recovering propionibacterial population included both susceptible and resistant strains. Changes during and post-treatment at the two centres were similar but not identical.. Oral isotretinoin effectively reduced skin and nasal colonization by antibiotic-resistant propionibacteria. However, viable populations of resistant isolates persisted post-treatment at multiple sites. Novel methods are required to eradicate antibiotic-resistant propionibacteria completely, especially from the nasal reservoir.

    Topics: Acne Vulgaris; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Drug Resistance, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Isotretinoin; Male; Microbial Sensitivity Tests; Middle Aged; Nose; Propionibacterium; Skin Diseases, Bacterial; Treatment Outcome

2005